HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sverre Mörk Selected Research

Multiple Sclerosis

6/2002VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sverre Mörk Research Topics

Disease

2Glioblastoma (Glioblastoma Multiforme)
07/2015 - 05/2006
2Astrocytoma (Pilocytic Astrocytoma)
07/2015 - 05/2006
1Neoplasms (Cancer)
05/2006
1Residual Neoplasm
06/2003
1Typical Teratoid Rhabdoid Tumor
06/2003
1Multiple Sclerosis
06/2002

Drug/Important Bio-Agent (IBA)

2TubulinIBA
07/2015 - 05/2006
2Proteins (Proteins, Gene)FDA Link
07/2015 - 05/2006
1NocodazoleIBA
05/2006
1pericentrinIBA
05/2006
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
06/2002

Therapy/Procedure

1Combined Modality Therapy
06/2003
1Drug Therapy (Chemotherapy)
06/2003